Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: Xetra
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

MRK:GR

101.230 EUR 0.229 0.23%

As of 11:35:18 ET on 05/22/2015.

Snapshot for Merck KGaA (MRK)

Open: 101.500 Day's Range: 100.850 - 101.850 Volume: 359,870
Previous Close: 101.459 52wk Range: 61.050 - 112.335 1-Yr Rtn: +63.04%

Stock Chart for MRK

No chart data available.
  • MRK:GR 101.300
  • 1D
  • 1M
  • 1Y
101.459
Interactive MRK Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for MRK

Current P/E Ratio (ttm) 39.8543
Estimated P/E(12/2015) 19.9941
Relative P/E vs. DAX 2.0937
Earnings Per Share (EUR) (ttm) 2.5400
Est. EPS (EUR) (12/2015) 5.0630
Est. PEG Ratio 3.6188
Market Cap (M EUR) 44,012.56
Shares Outstanding (M) 129.24
30 Day Average Volume 564,789
Price/Book (mrq) 3.1999
Price/Sale (ttm) 3.7557
Dividend Indicated Gross Yield 0.99%
Cash Dividend (EUR) 1.0000
Dividend Ex-Date 04/20/2015
5 Year Dividend Growth 14.87%
Next Earnings Announcement 08/06/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for MRK

  • Revenue
  • Net Income (M/EUR)
  • Profit Margin (%)

Company Profile & Key Executives for MRK

Merck KGaA is a global pharmaceutical and chemicals company. The Company researches drugs in the areas oncology and neurodegenerative as well as autoimmune and inflammatory diseases. Also, it markets cardiovascular, fertility, endocrinology, and over-the-counter products as well as products for flat screens and the pharmaceutical, food, cosmetics, packaging, and coatings.

Karl-Ludwig KleyChairman-Mgmt Board/CEOStefan OschmannDeputy CEO/Vice Chairman-Exec Board
Marcus KuhnertCFO/Member-Exec BoardKai BeckmannChief Administration Officer
More Company Profile & Key Executives for MRK

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil